leukemia/albumin

Lyen an sove nan clipboard la

Chwazi kalite sòt

8 rezilta yo

Polypeptide and polypeptide complex for suppressing tumor metastasis and treating leukemia as well as preparation method therefor and application thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CROSS-REFERENCE OF RELATED APPLICATION This application is a National Stage Application of PCT/CN2015/083021, filed Jul. 1, 2015, which claims priority to Chinese Patent Application No. 201410353810.5, filed Jul. 23, 2014 and Chinese Patent Application No. 201410497974.5, filed Sep. 25, 2014, the

Albumin-binding arginine deiminase and the use thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

COPYRIGHT NOTICE/PERMISSION A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure as it appears in the Patent and

Albumin-binding arginine deminase and the use thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Human immunosuppressive protein

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND 1. Technical Field The invention is in the fields of drug therapy; more specifically, the invention encompasses a protein for immunosuppression. 2. The Prior Art The central nervous system (CNS) actively maintains immune privilege (Carson and Sutcliffe, 1999; Fabry et al., 1994), in part

Long acting human interferon analogs

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to the manufacture and use of recombinant albumin fusion proteins to make human interferon analogs. The novel interferon analogs have the same functions with interferon in bio-assays, in vitro or in vivo. These long acting

Methods and compositions for treatment of a genetic condition

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNICAL FIELD The present disclosure is in the field of genome engineering. BACKGROUND Gene therapy holds enormous potential for a new era in human medicine. These methodologies will allow treatment for conditions that heretofore have not been addressable by standard medical practice. One area

Subcutaneously administrable composition containing anti-IL-6 antibody

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical

Method of treating allergic asthma with antibodies to IL-6

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The sequence listing in the file named "56256o2006.txt" having a size of 332,224 bytes that was created Sep. 26, 2017 is hereby incorporated by reference in its entirety. BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye